AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study

Health

AbbVie’s Rinvoq shows superiority over Humira in head-to-head arthritis study

Mon, Oct 20, 2025 0 Comments

Audio By Carbonatix

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company’s previous bestseller Humira, meeting the main goal of a head-to-head trial.

(Reporting by Puyaan Singh in Bengaluru)

Previous Exclusive-Kabul must rein in militants for ceasefire to hold, says Pakistan

Next Chinese battery maker CATL posts faster profit growth in third quarter

Salem News Channel | Today

More Health Headlines

Other News to Consider

Follow SRNNews.com

on Facebook

@SRNNews

Subscribe to our Newsletters RSS Feeds

Salem Media, our partners, and affiliates use cookies and similar technologies to enhance your browsing experience, analyze site traffic, personalize site content, and deliver relevant video recommendations. By using this website and continuing to navigate, you consent to our use of such technologies and the sharing of video viewing activity with third-party partners in accordance with the Video Privacy Protection Act and other privacy laws. Privacy Policy

X CLOSE

Email to a Friend

AbbVie’s Rinvoq shows superiority over Humira in head-to-head arthritis study

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company’s previous bestseller Humira, meeting the main goal of a head-to-head trial. (Reporting by Puyaan Singh in Bengaluru)

X close